By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


European Medicines Agency (EMA) 

7 Westferry Circus
Canary Wharf
London    E14 4HB  United Kingdom
Phone: 44-0-20-7523-7600 Fax: n/a



Company News
PIQUR Therapeutics AG Receives EMA Orphan Drug Designation For PQR309 In Diffuse Large B-Cell Lymphoma 4/27/2017 7:55:27 AM
uniQure (QURE) Receives EMA Priority Medicines (PRIME) Designation For AMT-060 In Hemophilia B 4/25/2017 9:01:25 AM
PhaseRx (PZRX) Receives Positive Opinion For Orphan Drug Designation For PRX-OTC From EMA 4/25/2017 7:02:09 AM
XBiotech (XBIT) Craters After Disappointing EMA Meeting 4/21/2017 8:48:59 AM
Cleveland Biolabs Inc. (CBLI) Announces EMA Positive Opinion Regarding The Entolimod Pediatric Investigation Plan 4/17/2017 10:44:07 AM
Thought Leaders From EMA, FDA, PMDA And IDDO To Headline 2017 CDISC Europe Interchange In London 3/31/2017 7:10:56 AM
NDA Group Releases Data Comparing FDA And EMA Ahead Of Annual DIA EuroMeeting In Glasgow 3/28/2017 12:39:28 PM
AcelRx (ACRX) Release: EMA Begins Evaluation Of Marketing Application For Sublingual Sufentanil 30 Mcg Tablet (Arx-04) For Moderate-To-Severe Acute Pain 3/28/2017 6:57:25 AM
EMA’s CHMP Recommends Approval Of Merck & Co. (MRK)’s KEYTRUDA (Pembrolizumab) For The Treatment Of Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma 3/24/2017 7:08:19 AM
Advaxis (ADXS) Release: EMA Certification Paves The Way For The MAA Submission For Axalimogene Filolisbac In Metastatic Cervical Cancer 3/23/2017 11:29:44 AM